Arquer Diagnostics (@ArquerDx) header
Arquer Diagnostics (@ArquerDx) profile picture

Arquer Diagnostics

@ArquerDx

#ArquerDiagnostics is leading the way in non-invasive tests for diagnosing and monitoring cancer. #ADXBLADDER is a game-changing urine test for #bladdercancer

 England
arquerdx.com
Joined July 2015
  • Tweets867
  • Following332
  • Followers251
587Media
Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)Photo by Arquer Diagnostics (@ArquerDx)
Well done @QEHResearch @GeordieGynae @WendyMc65962923 and the Team! Trials can only happen with the strong support of brilliant NHS individuals and patients' trust; let's deliver this much needed innovation to women around the world, together!
Gateshead Research and Development (@QEHResearch) profile pictureGateshead Research and Development@QEHResearch20 Jun 2022
Brilliant work from our Gynae research team 👏 👏
4
6
This is why our current European Uterine Clinical Trial on #uterinecancer #diagnostic urinary biomarker could be so fundamental for millions of #women around the world. #endometrialcancer #gyncancer #gyncsm #womenhealth @agz_eriksson
Ane Gerda Z Eriksson MD PhD (@agz_eriksson) profile pictureAne Gerda Z Eriksson MD PhD@agz_eriksson19 Jun 2022
📈#UterineCancer projected to become 3rd most common #cancer in #women #EndometrialCancer #GynCancer #gyncsm #womenshealth ⁦@nytimes⁩ ⁦@drcarolbrownMSK⁩ ⁦@KemiDoll⁩ ⁦@ShannonWestin⁩ ⁦@TeamEndo_MSK⁩ ⁦@Oslounivsykehus⁩ nytimes.com/2022/06/17/healt…
Uterine Cancer Is on the Rise, Especially Among Black Women (Published 2022)

Uterine Cancer Is on the Rise, Especially Among Black Women (Published 2022)

The cancer eventually will become the third most common type among women, experts say. The mortality rate is highest among Black Americans.

nytimes.com
2
4
Great to see narrative around pts empowerment getting stronger. Our #Clinicaltrial on a novel urine test for the detection of #endometrialcancer is now open in 9 UK centres and pts have embraced the opportunity to be part of #innovation in #uterinecancer @WombCancerUK @ucan2020
Patient Chat (@patientchat) profile picturePatient Chat@patientchat13 Jun 2022
Don't miss our Empowered #PatientChat, "Being a Decision-Maker in Clinical Trial Participation" on Twitter Spaces with @Srotberg15 and @KDRichardson924 on Friday, June 17th @ 10 AM PT/ 1 PM ET. powerfulpatients.org/event/e…
Image from Patient Chat (@patientchat)
3
6
Great work by the @NHSBartsHealth Team. #haematuria pathway improvements on the way thanks to the commitment and vision of all involved
This Post is from an account that no longer exists. Learn more
1
Manchester University NHS Foundation Trust is taking part in the national MCM5-UTERINE clinical study which aims to evaluate the performance of ADXGYNAE for detecting Endometrial Cancer in women suffering from post-menopausal bleeding.
Image from Arquer Diagnostics (@ArquerDx)
1
2
3
To be eligible for the trial you must have experienced post-menopausal bleeding and be undergoing investigations by a gynaecologist.
1
2
4
If you are attending St Marys Hospital, Manchester for investigations for post-menopausal bleeding and would like more information, please contact us on +44 (0) 191 516 6765 @manchesterunive @StMarysU @ucan2020 @EndometrialCanc
2
3
@ArquerDx are pleased to announce that Bedford Hospital is taking part in the national MCM5-UTERINE clinical study.
Image from Arquer Diagnostics (@ArquerDx)
1
2
1
5
To be eligible for the trial you must have experienced #postmenopausal bleeding and be undergoing investigation by a #gynaecologist
2
1
If you are attending Bedford Hospital for investigation for #postmenopausal bleeding and would like more information, please contact us on +44(0)1915166765 @EndometrialCanc @IGCSociety @ucan2020 @uterine
3
4
@ArquerDx are pleased to announce that University Hospital of North Durham are taking part in the national MCM5-UTERINE clinical study.
Image from Arquer Diagnostics (@ArquerDx)
1
3
4
more replies
|To be eligible for the trial you must have experienced #postmenopausal bleeding and be undergoing investigation by a #gynecologist
1
2
2
If you are attending University Hospital of North Durham for investigation for #postmenopausal bleeding and would like more information, please contact us on +44 (0) 191 516 6765
3
2
Let's not forget the many pts diagnosed with Bladder Cancer every year and the many Urologists/Associations/Companies focused on making their journey a safe and successful one! We continue to stand with them, every day.
Image from Arquer Diagnostics (@ArquerDx)
3
@ArquerDx are pleased to announce that Scunthorpe General Hospital and Diana Princess of Wales Hospital are taking part in the national MCM5-UTERINE clinical study.
Image from Arquer Diagnostics (@ArquerDx)
2
more replies
To be eligible for the trial you must have experienced #postmenopausal bleeding and be undergoing investigations by a gynaecologist.
1
If you are attending Scunthorpe General Hospital and Diana Princess of Wales Hospital for investigations for post-menopausal bleeding and would like more information, please contact us on +44 (0) 191 516 6765.
This is Laura Bardon our Technical Support Scientist. She says: “I joined the Arquer team because they are friendly and dynamic. The company vision is clear and everyone is working towards a shared goal.” #ThisIsArquer #Diagnostics
Image from Arquer Diagnostics (@ArquerDx)
Load more